Shivananjegowda, M.G.; Hani, U.; Osmani, R.A.M.; Alamri, A.H.; Ghazwani, M.; Alhamhoom, Y.; Rahamathulla, M.; Paranthaman, S.; Gowda, D.V.; Siddiqua, A.
Development and Evaluation of Solid Lipid Nanoparticles for the Clearance of Aβ in Alzheimer’s Disease. Pharmaceutics 2023, 15, 221.
https://doi.org/10.3390/pharmaceutics15010221
AMA Style
Shivananjegowda MG, Hani U, Osmani RAM, Alamri AH, Ghazwani M, Alhamhoom Y, Rahamathulla M, Paranthaman S, Gowda DV, Siddiqua A.
Development and Evaluation of Solid Lipid Nanoparticles for the Clearance of Aβ in Alzheimer’s Disease. Pharmaceutics. 2023; 15(1):221.
https://doi.org/10.3390/pharmaceutics15010221
Chicago/Turabian Style
Shivananjegowda, Meghana Goravinahalli, Umme Hani, Riyaz Ali M. Osmani, Ali H. Alamri, Mohammed Ghazwani, Yahya Alhamhoom, Mohamed Rahamathulla, Sathishbabu Paranthaman, Devegowda Vishakante Gowda, and Ayesha Siddiqua.
2023. "Development and Evaluation of Solid Lipid Nanoparticles for the Clearance of Aβ in Alzheimer’s Disease" Pharmaceutics 15, no. 1: 221.
https://doi.org/10.3390/pharmaceutics15010221
APA Style
Shivananjegowda, M. G., Hani, U., Osmani, R. A. M., Alamri, A. H., Ghazwani, M., Alhamhoom, Y., Rahamathulla, M., Paranthaman, S., Gowda, D. V., & Siddiqua, A.
(2023). Development and Evaluation of Solid Lipid Nanoparticles for the Clearance of Aβ in Alzheimer’s Disease. Pharmaceutics, 15(1), 221.
https://doi.org/10.3390/pharmaceutics15010221